Stable Isotopes Product Detail

4,5-Dichloro-1,3-benzenedisulfonyl Dichloride-13C6

Name: 4,5-Dichloro-1,3-benzenedisulfonyl Dichloride-13C6
Brand: Clearsynth
SKU: CS-T-99715
Availability: LimitedAvailability

Explore technical data, documentation access, molecular information and enquiry options for this Clearsynth research product.

Product Code: CS-T-99715 Stable Isotopes

4,5-Dichloro-1,3-benzenedisulfonyl Dichloride-13C6

API Family

Product Code

CS-T-99715

4,5-Dichloro-1,3-benzenedisulfonyl Dichloride-13C6

Stable Isotopes

Stock Status: : Enquire Live

CAT No.

CS-T-99715

CAS No.

Molecular Formula

¹³C₆H₂Cl₄O₄S₂

Molecular Weight

349.98

There is no hazardous surcharge associated with this product.

There is no packaging charge associated with this product.

For Research Purposes only. Not for Personal use.

All compounds supplied are strictly intended for laboratory, research, analytical, and scientific use only. They are not meant for human consumption, therapeutic use, or any form of clinical application.

CAS No.

Product Code

CS-T-99715

M.F.

¹³C₆H₂Cl₄O₄S₂

M.W.

349.98

Category

Stable Isotopes

Storage Condition

Refer MSDS for complete information.

IUPAC Name

"4,5-Dichloro-1,3-benzenedisulfonyl Dichloride-13C6"

References

"Brzozowski, Z. et al.: Eur. J. Med. Chem., 46, 3656 (2010); Tawil, R. et al.: Ann. Neurol., 47, 46 (2000); Casey, J. et al.: J. Med. Chem., 47, 2337 (2004);"

Synonyms

"1,2-Dichlorobenzene-3,5-disulfonyl Chloride-13C6; 1,2-Dichlorobenzene-4,6-disulfonyl Chloride-13C6; 4,5-Dichloro-m-benzenedisulfonyl Chloride-13C6;"

Application Notes

"4,5-Dichloro-1,3-benzenedisulfonyl Dichloride-13C6 is an intermediate used in the synthesis of Diclofenamide-13C6 (D436532), which is the labeled form of Diclofenamide, a potent carbonic anhydrase inhibitor. Diclofenamide may provide a therapeutic strategy in the inhibition of the human cytosolic isoforms I and II and transmembrane tumor-associated isoenzymes IX and XII. Diclofenamide has been shown to be is effective in the prevention of episodic weakness in both hypokalemic periodic paralysis (HypoPP) and potassium-sensitive periodic paralysis (PSPP)."

Hazard Compound

Refer MSDS for complete information.

Overview

Request Specification Download MSDS TSE / BSE Statement Retest Statement

Refund Policy

We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of material handover. We have invested in the highest quality packaging materials and use international logistics partners to service our customers. If there is an issue with one or more of our products, it must be reported to us within 45 days of your receiving shipment for refund or account credit eligibility.

4,5-Dichloro-1,3-benzenedisulfonyl Dichloride-13C6

4,5-Dichloro-1,3-benzenedisulfonyl Dichloride-13C6

Refund Policy

Tell us what you need

Selected RFQ Items

Chemical Services

Custom

4,5-Dichloro-1,3-benzenedisulfonyl Dichloride-13C6

4,5-Dichloro-1,3-benzenedisulfonyl Dichloride-13C6

Customers Also Viewed

N-Desbutyldronedarone hydrochloride D6

Erlotinib D4

Sulfosulfuron-D6(major)

Ibutilide Fumarate-d5

Retinyl Palmitate-d31

Dibenzo[e,l]pyrene-d14

N-Acetyl Sulfamethoxazole-13C6

Cardiolipin-d5

Hexadecyl Bromoacetate-13C2

Phthalic Acid Bis(1,2-dimethylpropyl) Ester-d4

Refund Policy

Tell us what you need

Selected RFQ Items